Literature DB >> 19180265

Retroviral bicistronic vectors.

Wolfgang Pfützner1.   

Abstract

The co-expression of genes can greatly enhance the efficiency and versatility of gene therapy applications. A variety of options exists to simultaneously express two genes in genetically modified cells. The most common approach relies on bicistronic vectors in which the genes are linked to each other by an internal ribosome entry site allowing co-translational expression of both cistrons. This review gives an overview of gene vector systems currently in use for coordinated expression of transgenes with particular focus on retroviral bicistronic vectors. The structural and functional characteristics of bicistronic vectors are discussed as well as factors influencing their efficiency such as the nature of the transgenes and the cell types in which they are expressed. Finally, the potential for clinical applications of retroviral bicistronic vectors in molecular genetics is highlighted. Copyright 2008 Prous Science, S.A.U. or its licensors. All rights reserved.

Mesh:

Year:  2008        PMID: 19180265     DOI: 10.1358/dnp.2008.21.9.1290817

Source DB:  PubMed          Journal:  Drug News Perspect        ISSN: 0214-0934


  4 in total

1.  Construction of recombinant adenovirus containing picorna-viral 2A-peptide sequence for the co-expression of neuro-protective growth factors in human umbilical cord blood cells.

Authors:  E E Garanina; Y O Mukhamedshina; I I Salafutdinov; A P Kiyasov; L M Lima; H J Reis; A Palotás; R R Islamov; A A Rizvanov
Journal:  Spinal Cord       Date:  2015-10-06       Impact factor: 2.772

2.  Insert sequence length determines transfection efficiency and gene expression levels in bicistronic mammalian expression vectors.

Authors:  Andrew J Payne; Bryan C Gerdes; Simon Kaja; Peter Koulen
Journal:  Int J Biochem Mol Biol       Date:  2013-12-15

3.  Optimisation of the foot-and-mouth disease virus 2A co-expression system for biomedical applications.

Authors:  Ekaterina Minskaia; John Nicholson; Martin D Ryan
Journal:  BMC Biotechnol       Date:  2013-08-22       Impact factor: 2.563

4.  Protein coexpression using FMDV 2A: effect of "linker" residues.

Authors:  Ekaterina Minskaia; Martin D Ryan
Journal:  Biomed Res Int       Date:  2013-06-12       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.